Zusammenfassung
Bei schwerem akutem Lungenversagen (ARDS), das durch konventionelle Therapie nicht ausreichend beherrscht werden kann, können zur Unterstützung des Gasaustauschs extrakorporale Systeme eingesetzt werden.
Pumpengetriebene Systeme (venovenöse extrakorporale Membranoxygenierung; vv-ECMO) sind indiziert, wenn eine therapierefraktäre Hypoxämie oder eine respiratorische Azidose (pH <7,2) vorliegen. Überlebensraten >50% werden bei schwerem ARDS unter vv-ECMO berichtet. Diese Systeme können etwa 50–80% des benötigten Gastransfers leisten und ermöglichen dadurch eine protektivere Beatmung, was das Ausmaß eines ventilatorinduzierten Lungenschadens begrenzt.
Pumpenlose Systeme („interventional lung assist“; iLA) mit arteriovenöser Kanülierung eignen sich zur Kohlendioxidelimination; primäre Indikation ist eine therapierefraktäre Hyperkapnie mit respiratorischer Azidose. Der Blutfluss wird hier durch die arteriovenöse Druckdifferenz generiert; eine eingeschränkte Pumpfunktion des Herzens oder ein niedriger mittlerer arterieller Blutdruck sind daher Kontraindikationen. Grundsätzlich können durch extrakorporale Systeme vielfältige Komplikationen auftreten, die eine lückenlose Überwachung von Patient und System erfordern.
Abstract
In severe acute lung failure, which cannot be handled by conventional therapeutic options, pump-driven systems (veno-venous extracorporeal membrane oxygenation, ECMO) or pumpless systems (interventional lung assist, iLA) can be used for extracorporeal lung assist.
A veno-venous ECMO is indicated in refractory hypoxaemia and/or in severe respiratory acidosis with a pH <7.2. Survival rates of more than 50% have been reported with the use of vv-ECMO in severe ARDS. Veno-venous extracorporeal systems can supply about 50–80% of the necessary gas exchange. Thus, a more protective ventilation is possible and the extent of the ventilator-induced lung injury is limited.
Pumpless devices with an arteriovenous cannulation are well suited for carbon dioxide elimination. Therefore, their primary indication is for refractory hypercapnia with respiratory acidosis. As the blood flow is generated exclusively by the arteriovenous pressure difference, a reduced cardiac pump function or a low mean arterial pressure must be considered a contraindication. Because many complications can potentially occur with the use of extracorporeal systems, close surveillance of the patient and device is essential.
Abbreviations
- ALI:
-
Acute lung injury
- aPTT:
-
Activated partial thromboplastin time
- ARDS:
-
Acute respiratory distress syndrome
- CESAR:
-
Conventional ventilation or ECMO for severe adult respiratory failure
- COPD:
-
Chronic obstructive pulmonary disease
- ECMO:
-
Extracorporeal membrane oxygenation
- ELSO:
-
Extracorporeal Life Support Organization
- FIO2 :
-
Fraction of inspired oxygen
- HFOV:
-
Hochfrequenz-Oszillationsventilation
- HIT II:
-
Heparininduzierte Thrombozytopenie Typ II
- iLA:
-
Interventional Lung Assist
- LIS:
-
Lung injury score
- MAP:
-
Mean arterial pressure
- NAVA:
-
Neurally adjusted ventilatory assist
- PAVK:
-
Periphere arterielle Verschlusskrankheit
- pECLA:
-
Pumpless extracorporeal lung assist
- PEEP:
-
Positive end-expiratory pressure
- PLS:
-
Permanent life support
- va:
-
Venoarteriell
- VILI:
-
Ventilator-induced lung injury
- vv:
-
Venovenös
Literatur
Arlt M, Philipp A, Zimmermann M et al (2008) First experience with a new miniaturized life support system for mobile percutaneous cardiopulmonary bypass. Resuscitation 77:345–350
Beiderlinden M, Eikermann M, Boes T et al (2006) Treatment of severe acute respiratory distress syndrome: role of extracorporeal gas exchange. Intensive Care Med 32:1627–1631
Bein T, Scherer MN, Philipp A et al (2005) Pumpless extracorporeal lung assist (pECLA) in patients with acute respiratory distress syndrome and severe brain injury. J Trauma 58:1294–1297
Bein T, Weber F, Philipp A et al (2006) A new pumpless extracorporeal interventional lung assist in critical hypoxemia/hypercapnia. Crit Care Med 34:1372–1377
Brogan TV, Thiagarajan RR, Rycus PT et al (2009) Extracorporeal membrane oxygenation in adults with severe respiratory failure: a multi-center database. Intensive Care Med 35:2105–2114
Brun-Buisson C, Minelli C, Bertolini G et al (2004) Epidemiology and outcome of acute lung injury in European intensive care units. Intensive Care Med 30:51–61
Combes A, Leprince P, Luyt CE et al (2008) Outcomes and long-term quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock. Crit Care Med 36:1404–1411
Elliot SC, Paramasivam K, Oram J et al (2007) Pumpless extracorporeal carbon dioxide removal for life-threatening asthma. Crit Care Med 35:945–948
Fischer F, Simon AR, Welte T et al (2006) Bridge to lung transplantation with the novel pumpless interventional lung assist device NovaLung. J Thorac Cardiovasc Surg 131:719–723
Gattinoni L, Pesenti A, Mascheroni D et al (1986) Low-frequency positive-pressure ventilation with extracorporeal CO2 removal in severe acute respiratory failure. JAMA 256:881–886
Hemmila MR, Rowe SA, Boules TN et al (2004) Extracorporeal life support for severe acute respiratory distress syndrome in adults. Ann Surg 240:595–607
Hill JD, O‘Brien TG, Murray JJ et al (1972) Prolonged extracorporeal oxygenation for acute post-traumatic respiratory failure (shock-lung syndrome). Use of the Bramson membrane lung. N Engl J Med 286:629–634
Horton S, Thuys C, Bennett M et al (2004) Experience with the Jostra Rotaflow and Quadrox D oxygenator for ECMO. Perfusion 19:17–23
Jackson A, Cropper J, Pye R et al (2008) Use of extracorporeal membrane oxygenation as a bridge to primary lung transplant: 3 consecutive, successful cases and a review of the literature. J Heart Lung Transplant 27:348–352
Karagiannidis C, Lubnow M, Philipp A et al (2010) Autoregulation of ventilation with neurally adjusted ventilatory assist on extracorporeal lung assist. Intensive Care Med, Aug 6, [epub ahead of print]
Kolla S, Awad SS, Rich BP et al (1997) Extracorporeal life support for 100 adult patients with severe respiratory failure. Ann Surg 226:544–566
Lewandowski K, Roissaint R, Pappert D et al (1997) High survival rate in 122 ARDS patients managed according to a clinical algorithm including extracorporeal membrane oxygenation. Intensive Care Med 23:819–835
Liebold A, Reng CM, Philipp A et al (2000) Pumpless extracorporeal lung assist – experience with the first 20 cases. Eur J Cardiothorac Surg 17:608–613
Lubnow M, Luchner A, Philipp A et al (2010) Combination of high frequency oscillatory ventilation and interventional lung assist in severe acute respiratory distress syndrome. J Crit Care, Jan 13 [epub ahead of print]
Mols G, Loop T, Geiger K et al (2000) Extracorporeal membrane oxygenation: a ten-year experience. Am J Surg 180:144–154
Morris AH, Fallace CJ, Menlove RL et al (1994) Randomized clinical trial of pressure-controlled inverse ratio ventilation and extracorporeal CO2 removal for adult respiratory distress syndrome. Am J Respir Crit Care Med 149:295–305
Mortensen JD (1987) An intravenacaval blood gas exchange (IVCB-GE) device: a preliminary report. Trans Am Soc Artif Intern Organs 33:570–573
Müller T, Lubnow M, Philipp A et al (2009) Extracorporeal pumpless interventional lung assist in clinical practice: determinants of efficacy. Eur Respir J 33:551–558
Müller T, Philipp A, Luchner A et al (2009) A new miniaturized system for extracorporeal membrane oxygenation in adult respiratory failure. Crit Care 13:R205
Peek GJ, Moore HM, Moore N et al (1997) Extracorporeal membrane oxygenation for adult respiratory failure. Chest 112:759–764
Peek GJ, Mugford M, Tiruvoipati R et al (2009) Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 374:1351–1363
Philipp A, Behr R, Reng M et al (1998) Pumpless extracorporeal lung assist. J Extra Corpor Technol 30:38–41
Phua J, Badia JR, Adhikari NKJ et al (2009) Has mortality from acute respiratory distress syndrome decreased over time? A systematic review. Am J Respir Crit Care Med 179:220–227
Reng M, Philipp A, Kaiser M et al (2000) Pumpless extracorporeal lung assist and adult respiratory distress syndrome. Lancet 356:219–220
Rubenfeld GD, Caldwell E, Peabody E et al (2005) Incidence and outcomes of acute lung injury. N Engl J Med 353:1685–1693
Schuerer DJ, Kolovos NS, Boyd KV, Coopersmith CM (2008) Extracorporeal membrane oxygenation: current clinical practice, coding and reimbursement. Chest 134:179–184
Schweikert WD, Pohlmann MC, Pohlmann AS et al (2009) Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial. Lancet 373:1874–1882
Vasilyev S, Schaap RN, Mortensen JD (1995) Hospital survival rates of patients with acute respiratory failure in modern respiratory intensive care units: an international, multicenter, prospective survey. Chest 107:1083–1088
Weber-Carstens S, Bercker S, Hommel M et al (2009) Hypercapnia in late-phase ALI/ARDS: providing spontaneous breathing using pumpless extracorporeal lung assist. Intensive Care Med 35:1100–1105
Zapol WM, Snider MT, Hill JD et al (1979) Extracorporeal membrane oxygenation in severe respiratory failure. A randomised prospective study. JAMA 242:2193–2196
Zimmermann M, Bein T, Arlt M et al (2009) Pumpless extracorporeal interventional lung assist in patients with acute respiratory distress syndrome: a prospective pilot study. Crit Care 13:R10
Zimmermann M, Bein T, Philipp A et al (2006) Interhospital transportation of patients with severe lung failure on pumpless extracorporeal lung assist. Br J Anaesth 96:63–66
Interessenkonflikt
Der korrespondierende Autor weist auf folgende Beziehungen hin: TM erhielt Vortragshonorare von der Firma Maquet Cardiopulmonary AG. ML gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Müller, T., Lubnow, M. Extrakorporale Lungenunterstützungssysteme. Pneumologe 7, 441–447 (2010). https://doi.org/10.1007/s10405-010-0410-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10405-010-0410-5
Schlüsselwörter
- Extrakorporale Membranoxygenierung (ECMO)
- Interventional lung assist (iLA)
- Adult respiratory distress syndrome (ARDS)
- Beatmungsbedingte Lungenschädigung
- Blutgasanalyse